Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19
- PMID: 36085364
- PMCID: PMC9461391
- DOI: 10.1038/s41390-022-02275-6
Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19
Abstract
Background: Given the sparse data on vitamin D status in pediatric COVID-19, we investigated whether vitamin D deficiency could be a risk factor for susceptibility to COVID-19 in Egyptian children and adolescents. We also investigated whether vitamin D receptor (VDR) FokI polymorphism could be a genetic marker for COVID-19 susceptibility.
Methods: One hundred and eighty patients diagnosed to have COVID-19 and 200 matched control children and adolescents were recruited. Patients were laboratory confirmed as SARS-CoV-2 positive by real-time RT-PCR. All participants were genotyped for VDR Fok1 polymorphism by RT-PCR. Vitamin D status was defined as sufficient for serum 25(OH) D at least 30 ng/mL, insufficient at 21-29 ng/mL, deficient at <20 ng/mL.
Results: Ninety-four patients (52%) had low vitamin D levels with 74 (41%) being deficient and 20 (11%) had vitamin D insufficiency. Vitamin D deficiency was associated with 2.6-fold increased risk for COVID-19 (OR = 2.6; [95% CI 1.96-4.9]; P = 0.002. The FokI FF genotype was significantly more represented in patients compared to control group (OR = 4.05; [95% CI: 1.95-8.55]; P < 0.001).
Conclusions: Vitamin D deficiency and VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents.
Impact: Vitamin D deficiency could be a modifiable risk factor for COVID-19 in children and adolescents because of its immune-modulatory action. To our knowledge, ours is the first such study to investigate the VDR Fok I polymorphism in Caucasian children and adolescents with COVID-19. Vitamin D deficiency and the VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents. Clinical trials should be urgently conducted to test for causality and to evaluate the efficacy of vitamin D supplementation for prophylaxis and treatment of COVID-19 taking into account the VDR polymorphisms.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19: correspondence.Pediatr Res. 2023 Apr;93(5):1110. doi: 10.1038/s41390-022-02348-6. Epub 2022 Oct 19. Pediatr Res. 2023. PMID: 36261502 Free PMC article. No abstract available.
Similar articles
-
FokI polymorphism of the vitamin D receptor gene: Linking COVID-19 risk to genetic susceptibility in children.Cytokine. 2025 Jul;191:156958. doi: 10.1016/j.cyto.2025.156958. Epub 2025 May 13. Cytokine. 2025. PMID: 40367829
-
Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19.Clin Endocrinol (Oxf). 2022 Jun;96(6):819-830. doi: 10.1111/cen.14664. Epub 2021 Dec 25. Clin Endocrinol (Oxf). 2022. PMID: 34919268
-
Increased susceptibility to complicated pneumonia among egyptian children with FokI (rs2228570), not TaqI (rs731236), vitamin D receptor gene polymorphism in association with vitamin D deficiency: a case-control study.BMC Pediatr. 2023 Aug 9;23(1):394. doi: 10.1186/s12887-023-04192-x. BMC Pediatr. 2023. PMID: 37559014 Free PMC article.
-
[Vitamin D and polymorphisms of VDR and GC genes in the severity and mortality from COVID-19. A systematic review].Nutr Hosp. 2022 Dec 20;39(6):1397-1407. doi: 10.20960/nh.04299. Nutr Hosp. 2022. PMID: 36327123 Spanish.
-
Vitamin D receptor gene polymorphism, serum 25-hydroxyvitamin D levels, and risk of vitiligo: A meta-analysis.Medicine (Baltimore). 2018 Jul;97(29):e11506. doi: 10.1097/MD.0000000000011506. Medicine (Baltimore). 2018. PMID: 30024533 Free PMC article. Review.
Cited by
-
Role of Vitamin D and Vitamin D Polymorphisms in COVID-19 Risk and Severity in Children: A Systematic Review.Cureus. 2024 May 29;16(5):e61326. doi: 10.7759/cureus.61326. eCollection 2024 May. Cureus. 2024. PMID: 38947671 Free PMC article. Review.
-
Vitamin D Status and Incidence of SARS-CoV-2 Reinfections in the Borriana COVID-19 Cohort: A Population-Based Prospective Cohort Study.Trop Med Infect Dis. 2025 Apr 6;10(4):98. doi: 10.3390/tropicalmed10040098. Trop Med Infect Dis. 2025. PMID: 40278771 Free PMC article.
-
Association of VDR and TMPRSS2 gene polymorphisms with COVID-19 severity: a computational and clinical study.Mol Biol Rep. 2025 Mar 19;52(1):327. doi: 10.1007/s11033-025-10417-2. Mol Biol Rep. 2025. PMID: 40106000
-
Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants.Sci Rep. 2023 Mar 3;13(1):3612. doi: 10.1038/s41598-023-30859-7. Sci Rep. 2023. PMID: 36869206 Free PMC article.
-
Relevance of Serum Levels and Functional Genetic Variants in Vitamin D Receptor Gene among Saudi Women with Gestational Diabetes Mellitus.Nutrients. 2023 Oct 8;15(19):4288. doi: 10.3390/nu15194288. Nutrients. 2023. PMID: 37836571 Free PMC article.
References
-
- World Health Organization. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int (2022).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous